The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-01
DOI
10.1111/bph.14382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
- (2018) S. Pablo Sardi et al. MOVEMENT DISORDERS
- Clinical approaches to the development of a neuroprotective therapy for PD
- (2017) C.W. Olanow et al. EXPERIMENTAL NEUROLOGY
- Brain aging and neurodegeneration: from a mitochondrial point of view
- (2017) Amandine Grimm et al. JOURNAL OF NEUROCHEMISTRY
- Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
- (2017) Giovanni B Frisoni et al. LANCET NEUROLOGY
- Bridging the gap: large animal models in neurodegenerative research
- (2017) S. L. Eaton et al. MAMMALIAN GENOME
- Animal models of α-synucleinopathy for Parkinson disease drug development
- (2017) James B. Koprich et al. NATURE REVIEWS NEUROSCIENCE
- Neural grafting for Parkinson's disease: challenges and prospects
- (2017) ThomasB Stoker et al. Neural Regeneration Research
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Neurotrophin receptors in the pathogenesis, diagnosis and therapy of neurodegenerative diseases
- (2017) Jacopo Meldolesi PHARMACOLOGICAL RESEARCH
- ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
- (2017) Dmitry Petrov et al. Frontiers in Aging Neuroscience
- Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders
- (2016) Taqi A. Khan et al. CNS & Neurological Disorders-Drug Targets
- Towards a Better Treatment Option for Parkinson’s Disease: A Review of Adult Neurogenesis
- (2016) Parisa Farzanehfar NEUROCHEMICAL RESEARCH
- Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3
- (2016) Carmen Rodríguez-Cueto et al. NEUROSCIENCE
- Biomarkers in Parkinson's disease: Advances and strategies
- (2016) Marion Delenclos et al. PARKINSONISM & RELATED DISORDERS
- A beacon of hope in stroke therapy—Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies
- (2016) Ashfaqul Hoque et al. PHARMACOLOGY & THERAPEUTICS
- Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases
- (2016) S. A. Youssef et al. VETERINARY PATHOLOGY
- CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
- (2016) Weili Yang et al. Frontiers in Molecular Neuroscience
- Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration
- (2015) Caio Mazucanti et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Genetically modified pig models for neurodegenerative disorders
- (2015) Ida E Holm et al. JOURNAL OF PATHOLOGY
- Engineering large animal models of human disease
- (2015) C Bruce A Whitelaw et al. JOURNAL OF PATHOLOGY
- Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
- (2015) Javier Fernández-Ruiz et al. Neurotherapeutics
- Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
- (2015) Renzo Mancuso et al. PROGRESS IN NEUROBIOLOGY
- Investigational drugs in Alzheimer's disease: current progress
- (2014) Camryn Berk et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats
- (2014) Mutsumi Fujii et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Stem cells for cell replacement therapy: A therapeutic strategy for HD?
- (2014) Anne Rosser et al. MOVEMENT DISORDERS
- Animal models of Huntington's disease for translation to the clinic: Best practices
- (2014) Liliana Menalled et al. MOVEMENT DISORDERS
- Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches
- (2014) Cristina Sampaio et al. MOVEMENT DISORDERS
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood–Brain Barrier
- (2014) Esmée Vendel et al. NEUROMOLECULAR MEDICINE
- Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias
- (2014) Carmen Rodríguez-Cueto et al. PATHOBIOLOGY
- Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
- (2013) In-Young Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers
- (2013) Sovan Sarkar BIOCHEMICAL SOCIETY TRANSACTIONS
- The influence of cannabinoids on generic traits of neurodegeneration
- (2013) S G Fagan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rationally Designed Multi-Targeted Agents Against Neurodegenerative Diseases
- (2013) W. J. Geldenhuys et al. CURRENT MEDICINAL CHEMISTRY
- The current and projected economic burden of Parkinson's disease in the United States
- (2013) Stacey L. Kowal et al. MOVEMENT DISORDERS
- Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
- (2013) Ismael Galve-Roperh et al. PROGRESS IN LIPID RESEARCH
- Recruiting adaptive cellular stress responses for successful brain ageing
- (2012) Alexis M. Stranahan et al. NATURE REVIEWS NEUROSCIENCE
- How can we improve clinical trials in amyotrophic lateral sclerosis?
- (2011) Paul H. Gordon et al. Nature Reviews Neurology
- CB1 receptor activation inhibits neuronal and astrocytic intermediary metabolism in the rat hippocampus
- (2011) João M.N. Duarte et al. NEUROCHEMISTRY INTERNATIONAL
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
- (2010) Nephi Stella GLIA
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Canine Degenerative Myelopathy
- (2010) Joan R. Coates et al. VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE
- Cannabidiol: A Promising Drug for Neurodegenerative Disorders?
- (2009) Teresa Iuvone et al. CNS Neuroscience & Therapeutics
- Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality
- (2009) Jeannie Hwang et al. LIFE SCIENCES
- CB2cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies
- (2007) Arévalo-Martín et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started